Fruzaqla (Fruquintinib)
- Medicine Name: Fruzaqla
- API: Fruquintinib
- Dosage Form & Strength: Capsules: 1 mg and 5 mg
- Manufactured By: Takeda
Fruzaqla (fruquintinib) is a kinase inhibitor used for the treatment of adult patients with metastatic colorectal cancer (mCRC) who have been previously taken treatment with fluoropyrimidine-, oxaliplatin-, and irinotecan-based chemotherapy, an anti-VEGF therapy, and, if RAS wild-type and medically apt, an anti-EGFR therapy.
Recommended Dosage: The recommended dose of Fruzaqla is 5 mg administered orally once daily for the first 21 days of each 28-day cycle until disease progression or unacceptable toxicity. Take Fruzaqla capsules with or without food at around the same time each day. Swallow the capsules whole.
Take a missed dose of Fruzaqla if less than 12 hours have passed since the missed scheduled dose. Do not take a couple of doses on the same day to make up for a missed dose. Avoid taking an additional dose in case vomiting occurs after taking the medicine but continue with the very next scheduled dose.
- Fruquintinib can cause hypertension. Avoid initiating therapy unless blood pressure is controlled. Monitor blood pressure weekly the initial month, at least monthly thereafter. Initiate or adjust anti-hypertensive therapy as appropriate. Withhold, reduce dose, or permanently stop therapy on behalf of the severity of hypertension.
- Treatment with Fruzaqla 1 mg/5 mg can cause serious hemorrhagic events, which may be fatal. Permanently stop treatment in patients with severe or life-threatening hemorrhage. Monitor the International Normalized Ratio (INR) levels in those receiving anticoagulants.
- Fruquintinib treatment can be responsible for causing an increased risk of infections, including fatal infections. Withhold therapy for Grade 3/4 infections, or worsening infection of any grade. Resume treatment at the same dose when the infection has resolved.
- The medicine Fruzaqla can cause liver injury. Monitor liver function tests (AST, ALT, and bilirubin) before starting and periodically throughout treatment. Temporarily hold and then reduce or permanently discontinue treatment on behalf of the severity and persistence of hepatotoxicity as manifested by elevated liver function tests.
- Fruquintinib can cause proteinuria. Monitor for proteinuria before initiation and periodically throughout treatment. For proteinuria ≥2 g/24 hours, withhold treatment until improvement to ≤Grade 1 proteinuria, and resume treatment at a reduced dose. Discontinue treatment in those who develop nephrotic syndrome.
What documents are required to import FRUZAQLA to India?
FRUZAQLA (fruquintinib) capsules can be imported by patients or government hospitals on the name of the patients only.
The following documentation is required to import the product:
- A valid prescription from a qualified doctor.
- Patients diagnostic reports
- Patients ID proof (issued by the government of India)
How does the order be confirmed?
The order will be confirmed only after the receipt of:
- A valid prescription from Doctor
- Import permit if applicable
Is FRUZAQLA available in India?
FRUZAQLA (fruquintinib capsules) is a (prescription drug, prescription medication, or prescription medicine) pharmaceutical drug that legally requires a medical prescription to be dispensed.
IPN (Indian Pharma Network) helps import cancer medicines on the named patient supply (NPS). Indian Pharma Network is the facilitator providing input
- On availability of Fruzaqla in India (Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Pune etc.)
- Medicine Price.
- Finding Genuine and reliable sources from the USA, Canada, Europe, and Australia
- Ensuring 100% transparency.
IPN (Indian Pharma Network) can facilitate the supply of FRUZAQLA (prescription medicines) to all locations in the world and in India after fulfilling the legal requirement (if applicable).
Please contact +91-9310090915 | Toll-Free Number: 1800-889-1064 or write us at info@indianpharmanetwork.in for Fruzaqla 1 mg/5 mg price in India.
We take to guarantee quality and delivery anywhere in the world as per the buyer’s requirements.
Indian Pharma Network is able to source the FRUZAQLA (Cancer Treatment Medicines) from across the globe and has the ability to supply. Indian Pharma offers its customers worldwide access to the best available treatment.
Indian Pharma Network (IPN) is able to dispense any valid prescription in the shortest possible time. All prescriptions are dispensed and checked by registered pharmacists and dispatched to the Patient’s address only from New Delhi, India.
What is the Generic Name for the trade name drug Fruzaqla®?
Fruquintinib is a Generic Name for the trade name drug Fruzaqla®.
What is the Manufacturer’s Name of Fruzaqla®?
Fruzaqla® is manufactured by Takeda Pharmaceuticals.
Is Fruzaqla® approved by the FDA?
Yes, Fruzaqla® is approved by the FDA. Date of first approval: November 8, 2023.
Where can I get Fruzaqla® at the best price in India?
To get the best Fruzaqla price in India, kindly contact the Indian Pharma Network (a WHO GDP and ISO 9001:2008 certified company). For Fruzaqla®, a medical prescription is needed from a treating physician.
What is the dosage and form of Fruzaqla® supplied?
Fruzaqla® is supplied as Capsules: 1 mg and 5 mg for oral administration.
What are the most common side effects of Fruzaqla®?
The most common side effects of Fruzaqla® are hypertension, palmar-plantar erythrodysesthesia, abdominal pain, diarrhea, proteinuria, dysphonia, and asthenia.
How much does Fruzaqla® cost in India?
The cost of Fruzaqla in India can vary. To procure this medication legally, you can call or WhatsApp +91-9310090915 or send mail to info@indianpharmanetwork.in.
What are the storage conditions of Fruzaqla®?
Store this medicinal product at 20°C to 25°C (68°F to 77°F). Brief exposure to 15°C and 30°C (59°F to 86°F) permitted.
Is it safe to buy Fruzaqla® online in India?
Yes, one can buy Fruzaqla online in India at the lowest price from the Indian Pharma Network (IPN) if this medicinal product is not (yet) registered or available in their country. We can help facilitate the supply of Fruzaqla® through legal channels.
Contact Patient Support
If you have any questions or need any help, contact our Patient Support Team. We will get in touch with you within 24 hours from Monday to Friday between 9:00 and 10:00 CET.
Disclaimer
All Trademarks and Brands that appear on the website belong to their respective owners and indianpharmanetwork does not lay any claim on them we only provide Information.